Difficulty: Medium
Average Score: 81%
Practice
What is ONE gene mutation typically associated with MarfanÔÇÖs syndrome?
Correct answer
A
Rationale
Marfan's syndrome is a genetic disorder that affects the body's connective tissue, primarily in the cardiovascular, ocular, and skeletal systems. The gene mutation typically associated with Marfan's syndrome is FBN1, which encodes for fibrillin-1, a crucial component of microfibrils in the extracellular matrix. Mutations in FBN1 lead to structural weakness in connective tissue, resulting in the characteristic features of Marfan's syndrome.
Option A (FBN1) is correct because mutations in this gene are well-documented in individuals with Marfan's syndrome. Option B (ACTA2) is associated with a different condition called familial thoracic aortic aneurysm and dissection, not Marfan's syndrome. Option C (SIX2) is related to developmental abnormalities in the kidney and not associated with Marfan's syndrome. Option D (TGFBR2) mutations are linked to Loeys-Dietz syndrome, another connective tissue disorder distinct from Marfan's syndrome.
Understanding the genetic basis of Marfan's syndrome is crucial for healthcare providers, especially in pediatrics, as early diagnosis and management can significantly impact patient outcomes. Recognizing the specific gene mutation associated with Marfan's syndrome helps in providing targeted interventions and genetic counseling to affected individuals and their families.
Option A (FBN1) is correct because mutations in this gene are well-documented in individuals with Marfan's syndrome. Option B (ACTA2) is associated with a different condition called familial thoracic aortic aneurysm and dissection, not Marfan's syndrome. Option C (SIX2) is related to developmental abnormalities in the kidney and not associated with Marfan's syndrome. Option D (TGFBR2) mutations are linked to Loeys-Dietz syndrome, another connective tissue disorder distinct from Marfan's syndrome.
Understanding the genetic basis of Marfan's syndrome is crucial for healthcare providers, especially in pediatrics, as early diagnosis and management can significantly impact patient outcomes. Recognizing the specific gene mutation associated with Marfan's syndrome helps in providing targeted interventions and genetic counseling to affected individuals and their families.